Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Schiffer

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Brain Communications|November 10, 2021
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approachTianrong Yeo, Fay Probert, Megan Sealey, et al.
Electrophoresis|April 29, 2006
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separationPetra Zürbig, Matthew B Renfrow, Eric Schiffer, et al.
Journal of Proteome Research|December 5, 2008
Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patientsConstantin von Zur Muhlen, Eric Schiffer, Petra Zuerbig, et al.
Pediatric Nephrology (Berlin, Germany)|February 25, 2010
Urinary proteome analysis identifies infants but not older children requiring pyeloplastyJens Drube, Petra Zürbig, Eric Schiffer, et al.
Molecular & Cellular Proteomics : MCP|October 24, 2007
Urinary proteomic biomarkers in coronary artery diseaseLukas U Zimmerli, Eric Schiffer, Petra Zürbig, et al.
Hepatology (Baltimore, Md.)|March 5, 2011
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasisTim O Lankisch, Jochen Metzger, Ahmed A Negm, et al.
Journal of Hypertension|September 3, 2010
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individualsChristian Delles, Eric Schiffer, Constantin von Zur Muhlen, et al.
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Electrophoresis|November 16, 2007
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseasesBruce A Julian, Stefan Wittke, Jan Novak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Role of B vitamins in modulating homocysteine and metabolic pathways linked to brain atrophy: Metabolomics insights from the VITACOG trialTereza Kacerova, Abi G Yates, Jiayi Dai, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Brain Communications|November 10, 2021
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approachTianrong Yeo, Fay Probert, Megan Sealey, et al.
Electrophoresis|April 29, 2006
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separationPetra Zürbig, Matthew B Renfrow, Eric Schiffer, et al.
Journal of Proteome Research|December 5, 2008
Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patientsConstantin von Zur Muhlen, Eric Schiffer, Petra Zuerbig, et al.
Pediatric Nephrology (Berlin, Germany)|February 25, 2010
Urinary proteome analysis identifies infants but not older children requiring pyeloplastyJens Drube, Petra Zürbig, Eric Schiffer, et al.
Molecular & Cellular Proteomics : MCP|October 24, 2007
Urinary proteomic biomarkers in coronary artery diseaseLukas U Zimmerli, Eric Schiffer, Petra Zürbig, et al.
Hepatology (Baltimore, Md.)|March 5, 2011
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasisTim O Lankisch, Jochen Metzger, Ahmed A Negm, et al.
Journal of Hypertension|September 3, 2010
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individualsChristian Delles, Eric Schiffer, Constantin von Zur Muhlen, et al.
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Electrophoresis|November 16, 2007
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseasesBruce A Julian, Stefan Wittke, Jan Novak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Role of B vitamins in modulating homocysteine and metabolic pathways linked to brain atrophy: Metabolomics insights from the VITACOG trialTereza Kacerova, Abi G Yates, Jiayi Dai, et al.
Pageof 6